Oncolytics Biotech (ONCY) Debt Ratio (2019 - 2025)

Oncolytics Biotech (ONCY) has reported Debt Ratio for 7 consecutive years, with 0.01 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Debt Ratio fell 79.08% year-over-year to 0.01 in Q4 2025; TTM through Dec 2025 was 0.01, a 79.08% decrease from a year earlier, with the FY2025 full-year figure at 0.01, down 80.96% from the prior year.
• Debt Ratio was 0.01 for Q4 2025 at Oncolytics Biotech, up from 0.0 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.11 in Q3 2023 and troughed at 0.0 in Q2 2022.
• A 5-year average of 0.02 and a median of 0.0 in 2021 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 8682.46% in 2023 and slumped 95.72% in 2025, its largest moves.
• Over 5 years, Debt Ratio stood at 0.0 in 2021, then jumped by 73.36% to 0.0 in 2022, then surged by 5229.87% to 0.11 in 2023, then tumbled by 56.96% to 0.05 in 2024, then tumbled by 79.08% to 0.01 in 2025.
• The last three Debt Ratio figures came in at 0.01 (Q4 2025), 0.0 (Q3 2025), and 0.05 (Q2 2025), per Business Quant data.